Revolo obtains MHRA approval for autoimmune disease drug trials
The UK MHRA has granted approval to initiate two Phase II trials of Revolo Biotherapeutics’ ‘1805 to treat autoimmune diseases.
Stay updated with breaking news from Jonathan Rigby. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The UK MHRA has granted approval to initiate two Phase II trials of Revolo Biotherapeutics’ ‘1805 to treat autoimmune diseases.
Revolo Biotherapeutics Receives MHRA Approval for Two Phase 2 Clinical Trials of ‘1805 in Autoimmune Diseases in the United Kingdom
Company to initiate one Phase 2 trial in rheumatoid arthritis and a second Phase 2 trial in uveitis...
The quality of 'The Vampire Lovers' is amazing for a low-budget film from the 1970s. They took the original Eastman Color negatives and gave them a serious upgrade.
Revolo Biotherapeutics Announces the Appointment of Tunde Otulana, M.D., to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace